Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors

Ebola virus (EBOV) can cause severe hemorrhagic fever in humans, and no approved treatment is currently available. Although several antibodies have achieved good protection in animal models, the potential emerging isolates of ebolavirus and the unknown effects of experimental antibodies in humans un...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Pengfei, Chi, Xiangyang, Liu, Guodong, Zhang, Guanying, Chen, Zhengshan, Liu, Yujiao, Fang, Ting, Li, Jianmin, Banadyga, Logan, He, Shihua, Yu, Changming, Qiu, Xiangguo, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153831/
https://www.ncbi.nlm.nih.gov/pubmed/32213108
http://dx.doi.org/10.1080/19420862.2020.1742457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153831/
https://www.ncbi.nlm.nih.gov/pubmed/32213108
http://dx.doi.org/10.1080/19420862.2020.1742457

Ejemplares similares